A simple, economical, and reproducible high-performance liquid chromatography mass spectrometric (MS) method is developed and validated for the determination of amoxicillin in human plasma. The present method has been successfully used to determine bioequivalence between a test and innovator formulation of amoxicillin 500 mg capsules. The method is validated in terms of selectivity, precision/accuracy, recovery, dilution integrity, matrix effect, effect of anti-coagulant, and stability studies. Sample preparation is carried out by solid-phase extraction (HLB Oasis cartridges). The processed sample is chromatographed on Hypersil Gold (4.6 x 50 mm); 3 microm C18 column, using 10mM ammonium formate buffer (pH 5.0) and acetonitrile, (10:90, v/v) as mobile phase. Amoxicillin is detected by MS-MS detection with turbo-ion spray in positive ion mode. The weighed (1/X2) calibration curves were linear over the range of 0.17 to 17.0 microg/mL. The intra day precision is from 1.3% to 8.8% and intra day accuracy is 94.1% to 108.5%. The inter day precision is from 1.8% to 6.2% and inter-day accuracy is 95.1% to 105.9%. Mean recovery of 66.3% is observed for amoxicillin and 71.6% for internal standard (ampicillin). The stability of amoxicillin is studied at -15 degrees C and -50 degrees C using human plasma with different anti-coagulants (citrate, monobasic sodium phosphate, dextrose, and adenine-citrate, monobasic sodium phosphate, dextrose, and adenine and ethylene diamine tetraacetic acid-ethylene diamine tetraacetic acid). No significant degradation is observed for 60 days.
No takes yet. Share an insight, caveat, or question.
Khuroo et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: